Ramifications of a redox switch within a normal cell: Its absence in a cancer cell

Free Radical Biology and Medicine

Volumn 45, Issue 3, 2008, Pages 265-268

  Hoffman, A ^a   Spetner, L M ^a   Burke, M ^a,b  

^a Redoxia   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Aneuploidy; Apoptosis; Cancer; Cell cycle; Intracellular redox potential; Uncontrolled proliferation; Warburg effect

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; CARCINOGEN; CIGARETTE SMOKE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HYPOXIA INDUCIBLE FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANEUPLOIDY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CHROMOSOME ABERRATION; CIGARETTE SMOKING; ENZYME ACTIVITY; GLYCOLYSIS; NEOPLASM; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATION-REDUCTION; SMOKING;

EID: 46449093895     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.03.025     Document Type: Article

References (28)

1. Pardee A.B. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 1 (1974) 103-110
2. 1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 5365-5369
3. Zetterberg A., Larsson O., and Wiman K.G. What is the restriction point?. Curr. Opin. Cell Biol. 7 (1995) 835-842
4. Malumbres M., and Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat. Rev., Cancer 1 (2001) 222-231
5. Blagosklonny M.V., and Pardee A.B. The restriction point of the cell cycle. Cell Cycle 1 (2002) 103-110
6. Hoffman A., Spetner L.M., and Burke M. Cessation of cell proliferation by adjustment of cell redox potential. J. Theor. Biol. 211 (2001) 403-407
7. Menon S.G., Sarsour E.H., Spitz D.R., Higashikubo R., Sturm M., Zhang H., et al. Redox regulation of the G1 to S phase transition in the mouse embyro fibroblast. Cancer Res. 63 (2003) 2109-2117
8. Hutter D.E., Till B.G., and Greene J.J. Redox state changes in density-dependent regulation of proliferation. Exp. Cell Res. 232 (1997) 435-438
9. 1pm. Theor. Biol. Med. Model 3, 26.
10. Menon S.G., Coleman M.C., Walsh S.A., Spitz D.R., and Goswami P.C. Differential susceptibility of nonmalignant human breast epithelial cells and breast cancer cells to thiol antioxidant-induced G(1)-delay. Antioxid. Redox Signal. 7 (2005) 711-718
11. Cerdan S., Rodrigues T.B., Sierra A., Benito M., Fonseca L.L., Fonseca C.P., et al. The redox switch/coupling hypothesis. Neurochem. Int. 48 (2006) 523-530
12. Menon S.G., and Goswami P.C. A redox cycle within the cell cycle; ring in the old with the new. Oncogene 26 (2007) 1101-1109
13. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
14. Sen C.K. Cellular thiols and redox-regulated signal transduction. Curr. Top. Cell Regul. 361 (2000) 1-30
15. Cotgreave I.A., and Gerdes R.G. Recent trends in glutathione biochemistry-glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation. Biochem. Biophys. Res. Commun. 242 (1998) 1-9
16. Tamrakar S., Rubin E., and Ludlow J.W. Role of pRB dephosphorylation in cell cycle regulation. Front. Biosci. 5 (2000) D121-D137
17. 2] glucose. Am. J. Physiol. Endocrinol. Metab. 174 (1998) E843-E851
18. Minet E., Michel G., Mottet D., Raes M., and Michiels G. Transduction pathways involved in hypoxia-inducible factor-1 phosphorylation and activation. Free Radic. Biol. Med. 31 (2001) 847-855
19. Lu H., Forbes R.A., and Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J. Biol. Chem. 277 (2002) 23111-23115
20. Weaver B.A., and Cleveland D.W. Does aneuploidy cause cancer?. Curr. Opin. Cell Biol. 18 (2006) 658-667
21. Duesberg P., Li R., Fabarius A., and Hehlmann R. The chromosomal basis of cancer. Cell Oncol. 27 (2005) 293-318
22. Woodbury E.L., and Morgan D.O. Cdk and APC activities limit the spindle-stabilizing function of Fin1 to anaphase. Nat. Cell Biol. 9 (2006) 106-112
23. Morrison D., Rahman I., Lannan S., and MacNee W. Epithelial permeability, inflammation and oxidant stress in air spaces of smokers. Am. J. Respir. Crit Care Med. 159 (1999) 473-479
24. Woynarowska B.A., Woynarowski J.M., Herzig M.C., Roberts K., Higdon A.L., and MacDonald J.R. Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF). Biochem. Pharmacol. 59 (2000) 1217-1226
25. Nkabyo Y.S., Ziegler T.R., Gu L.H., Watson W.H., and Jones D.P. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am. J. Physiol. Gasterointest. Liver physiol. 283 (2002) G1352-G1359
26. Hanigan M.H. Gamma-glutamyl transpeptidase, a glutathionase: its expression and function in carcinogenesis. Chem.-Biol. Interact. 111-112 (1998) 333-342
27. Järvinen KJ (2001) Antioxidant enzymes and related mechanisms in malignant pleural mesothelioma. Academic dissertation. Hospital for Children and Adolescents, University of Helsinki (Dissertation Department of Internal Medicine, University of Oulu) Finland.
28. Pompella A., De Tata V., Paolicchi A., and Zunino F. Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance. Biochem. Pharmacol. 71 (2006) 231-238